Abstract
Recombinant alpha-interferon has shown antitumour activity in renal cell carcinoma and malignant melanoma, both of which are very resistant to conventional cytotoxic treatment. It is likely that in the future recombinant interferons will be used in combination with cytotoxic chemotherapy in the treatment of these two tumour types.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Krown SE, Burk MW, Kirkwood JM et al.: Human leukocyte (alpha) interferon in metastatic malignant melanoma: The American Cancer Society Phase II Trial. Cancer Treat Rep 1984 (68):723–726
Legha SS: Interferons in the treatment of malignant melanoma. A review of recent trials. Cancer 1986 (57):1675–1677
Creagan ET, Ahmann DL, Green SJ et al.: Phase II study of recombinant leukocyte A interferon in disseminated malignant melanoma. Cancer 1984 (54):2844–2849
Parlson DF, Perez CA, Anderson T: Cancer of the kidney and ureter. In: De Vita VT jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and practice of oncology. Philadelphia: JB Lippincott 1985:895–914
Bloom HJG: Hormone induced and spontaneous regression of metastatic renal cancer. Cancer 1983 (32):1066- 1071
Montie JE, Stewart BH, Straffon RA et al.: The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol 1977 (117):272–275
Quesada JR, Swanson DA, Trindade A et al.: Renal cell carcinoma: antitumor effects of leukocyte interferon. Cancer Res 1983 (43):940–947
Neidhart JA: Interferon therapy for the treatment of renal cancer. Cancer 1986 (57):1696–1699
Aapro M, Alberts DS, Salmon SE: Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay. Cancer Chemother Pharmacol 1983 (10):161–166
Fossa SD, De Garis ST, Heier MS et al.: Recombinant interferon alpha-2 A with or without vinblastine in metastatic renal cell carcinoma. Cancer 1986 (57):1700–1704
Balkwill FR: Antitumor effects of interferons in animals. In: Interferon, volume 4: In vivo and clinical studies. Elsevier Science Publishers BV 1985: 23–45
Welander CE, Muss HB, Morgan TM et al.: Synergy in vitro and in clinical trials. In: Kisner D and Smith J (eds) Interferon alpha-2: Preclinical and clinical evaluation. Martinus Nijhoff Publishers 1985: 29–40
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Martinelli, G., Cavalli, F. (1987). Alpha-Interferon Alone or in Combination with Chemotherapy in the Treatment of Malignant Melanoma, Renal Cell Carcinoma and other Solid Tumours. In: Smyth, J.F. (eds) Interferons in Oncology. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72805-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-72805-1_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72807-5
Online ISBN: 978-3-642-72805-1
eBook Packages: Springer Book Archive